Does hormone therapy, tibolone or raloxifene modify VEGF expression in cervical epithelial cells? [electronic resource]
Producer: 20120727Description: 181-5 p. digitalISSN:- 1473-0804
- Aged
- Androstenedione -- blood
- Cervix Uteri -- metabolism
- Contraceptives, Oral, Synthetic -- pharmacology
- Cross-Sectional Studies
- Epithelial Cells -- metabolism
- Estradiol -- pharmacology
- Estrogen Antagonists -- pharmacology
- Estrogen Receptor Modulators -- pharmacology
- Estrogens -- pharmacology
- Female
- Humans
- Metaplasia -- metabolism
- Middle Aged
- Norethindrone -- analogs & derivatives
- Norethindrone Acetate
- Norpregnenes -- pharmacology
- Papanicolaou Test
- Postmenopause -- blood
- Raloxifene Hydrochloride -- pharmacology
- Statistics, Nonparametric
- Vaginal Smears
- Vascular Endothelial Growth Factor A -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.